- ￥200000
- Qiagen
- 14900-100-NF
- 2025年07月16日
企业认证
相关产品推荐更多 >
CellGenix特约代理商|20801-0500 CellGenix® GMP DC
￥3000seracare特约代理商|0710-0094 Seraseq® Tumor Mutation DNA Mix v2 AF 10 HC
￥3000ADI特约代理商|CP17-C Rat Ceruloplasmin protein control for western blot
￥3000lifecore biomedical 特约代理商|HA500K-5 sodium hyaluronate,research grade透明质酸301KDa-450KDa
￥3000ambion特约代理商|am10027 Magnetic Stand-96
￥3000
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
100
- 供应商：
上海玉博生物科技有限公司
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验does not to be changed after transfection. siRNA transfection is also possible by using TransIT-TKO: small interfering RNA (siRNA) Transfection Reagent , which is provided by Mirus . Transit-TKO reagent is more difficult to handle than OLIGOFECTAMINE
after transfection. siRNA transfection is also possible by using TransIT-TKO: small interfering RNA (siRNA) Transfection Reagent , which is provided by Mirus . Transit-TKO reagent is more difficult to handle than OLIGOFECTAMINE, because concentrations required
RNA (siRNA) Transfection Reagent , which is provided by Mirus . Transit-TKO reagent is more difficult to handle than OLIGOFECTAMINE, because concentrations required for effective transfection also cause cytotoxic effects. Typical side effects
技术资料暂无技术资料 索取技术资料
